in Biology (Magna Cum Laude) from Williams College. DiPersio and his staff because I trust them with my life.

from the University of Rochester and a B.A. But I know that if I have to go through this again, I will do it with Dr. He graduated from University of Rochester in 1980. Dipersio has extensive experience in Skeletal System Neoplasms, Blood Cancers, and Blood Disorders. Find all Ingredients for Adhesives & Sealants from D&R Dispersions and Resins and access the knowledge to select them through Industry News, Articles, Selection Guides, Formulations and Patents. John Dipersio, MD is a Hematology Specialist in Saint Louis, MO and has over 42 years of experience in the medical field. He has authored or co-authored more than 450 publications.ĭr. DiPersios clinical research focuses on fundamental and translational aspects of leukemia and stem cell biology. John F Dipersio specializes in medical oncology, practices at 4921 Parkview Place, phone number, opening hours. John Dipersio, MD Hematology Male Age 71 Dr. Schuster Distinguished Translational Investigator Award from Washington University in St. DiPersio is past Chair of ASH Scientific Committee on Hematopoiesis, immediate past President of the American Society of Transplantation and Cellular Therapy, a member of the Board of Scientific Counselors (Clinical Science and Epidemiology) of the National Cancer Institute, and the 2013 recipient of the Daniel P. Food and Drug Administration in 20 respectively, for the treatment of multiple myeloma, non-Hodgkin’s lymphoma and graft versus host disease.ĭr. It is mounted into dissolution apparatus 2 of the United States Pharmacopoeia. DiPersios research focuses on fundamental and translational aspects of leukemia and stem cell biology. DiPersio was instrumental in developing two drugs, Plerixafor and Ruxolitinib, approved by the U.S. The dispersion releaser (DR) is a dialysis-based setup for the analysis of the drug release from nanosized drug carriers. These studies include identification of genetic abnormalities in human leukemias, understanding processes involving stem cell and leukemia cell trafficking, and clinical and translational programs in both leukemia/myelodysplastic syndrome and transplantation immunology.Īmong his many accomplishments, Dr. DiPersio’s clinical research focuses on fundamental and translational aspects of leukemia and stem cell biology. Trade & Generic Names & General Features Amphotericin B colloidal dispersion (ABCD) is a lipid formulation of amphotericin B. DiPersio is Chief of the Division of Oncology, Deputy Director of the Siteman Cancer Center at Washington University School of Medicine in St. Siteman Cancer Center and Chief of the Division of Oncology at Washington University School of Medicine in.

Dr. dispersio